Octinoxate Completed Phase 4 Trials for Melasma Treatment
Indications | Status | Purpose | Phase |
---|---|---|---|
Completed | Treatment | 4 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT01695356 | Ultraviolet and UV-Visible Light Photoprotection for the Treatment of Melasma |
Indications | Status | Purpose | Phase |
---|---|---|---|
Completed | Treatment | 4 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT01695356 | Ultraviolet and UV-Visible Light Photoprotection for the Treatment of Melasma |